Literature DB >> 12882811

Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization.

Diego G Espinosa-Heidmann1, Ivan J Suner, Eleut P Hernandez, Dagoberto Monroy, Karl G Csaky, Scott W Cousins.   

Abstract

PURPOSE: Macrophage recruitment to the choroid has been proposed to contribute to the pathogenesis of choroidal neovascularization (CNV) in AMD. The study was conducted to determine whether treatment with clodronate liposomes (CL(2)MDP-lip), which cause depletion of blood monocytes and lymph node macrophages, diminishes the severity of neovascularization in a mouse model of laser-induced CNV.
METHODS: Laser-induced CNV was performed in female 16-month-old C57BL/6 mice. Macrophages were depleted by use of CL(2)MDP-lip intraperitoneally and subcutaneously 72 and 24 hours before and every 2 to 3 days after laser injury. Control mice received injections of either PBS alone or PBS liposomes. Blood monocyte and choroidal macrophage depletion were documented by flow cytometry and choroidal flatmount preparation analysis, respectively. Two weeks after laser injury, mice were injected intravenously with fluoresceinated dextran. The right eyes were removed and prepared for flatmount analysis of CNV surface area (in relative disc areas or DA), vascularity (relative fluorescence), and cellularity (propidium iodide stain). The mice were then perfused with 10% formaldehyde, and the left eyes were removed for histopathology. The means of the various parameters for four CNV lesions per eye were calculated. Fluorescein angiography was also performed.
RESULTS: Flow cytometry of circulating monocytes and immunohistochemical analysis of choroidal macrophage density confirmed the effective depletion of blood monocytes and choroidal macrophages respectively in CL(2)MDP-lip-treated mice. Compared with the control, flatmount analysis of macrophage depleted mice demonstrated a significant reduction in size of the CNV area (2.8 +/- 0.5 DA vs. 1.4 +/- 0.1 DA; P < 0.043). The treated group also revealed less vascularity (1.6 +/- 0.1 units vs. 1.1 +/- 0.0 units; P < 0.0092) and cellularity of CNV lesions (3.3 +/- 0.6 DA vs. 1.7 +/- 0.1 DA, P < 0.04). Histopathology revealed that, in the macrophage-depleted group, CNV was smaller in diameter (1270 +/- 73 pixels vs. 770 +/- 82 pixels, P < 0.0006) and thickness (120 +/- 7 pixels vs. 96 +/- 7 pixels, P < 0.019).
CONCLUSIONS: Macrophage depletion using CL(2)MDP-lip reduces size, cellularity, and vascularity of CNV. This observation supports the hypothesis that macrophages contribute to the severity of CNV lesions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12882811     DOI: 10.1167/iovs.03-0038

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  167 in total

Review 1.  The stereotypical molecular cascade in neovascular age-related macular degeneration: the role of dynamic reciprocity.

Authors:  D Kent
Journal:  Eye (Lond)       Date:  2015-07-31       Impact factor: 3.775

2.  Photodynamic treatment versus photodynamic treatment associated with systemic steroids for idiopathic choroidal neovascularisation.

Authors:  Alfonso Giovannini; Piergiorgio Neri; Lucia Mercanti; Claudia Bruè
Journal:  Br J Ophthalmol       Date:  2007-01-03       Impact factor: 4.638

3.  Obligatory participation of macrophages in an angiopoietin 2-mediated cell death switch.

Authors:  Sujata Rao; Ivan B Lobov; Jefferson E Vallance; Kaoru Tsujikawa; Ichiro Shiojima; Shailaja Akunuru; Kenneth Walsh; Laura E Benjamin; Richard A Lang
Journal:  Development       Date:  2007-12       Impact factor: 6.868

4.  Retinal vascular repair and neovascularization are not dependent on CX3CR1 signaling in a model of ischemic retinopathy.

Authors:  Lian Zhao; Wenxin Ma; Robert N Fariss; Wai T Wong
Journal:  Exp Eye Res       Date:  2009-01-07       Impact factor: 3.467

Review 5.  Ocular neovascularization.

Authors:  Peter A Campochiaro
Journal:  J Mol Med (Berl)       Date:  2013-01-18       Impact factor: 4.599

6.  Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort.

Authors:  Jie Jin Wang; Elena Rochtchina; Wayne Smith; Ronald Klein; Barbara E K Klein; Tripti Joshi; Theru A Sivakumaran; Sudha Iyengar; Paul Mitchell
Journal:  Am J Epidemiol       Date:  2008-12-13       Impact factor: 4.897

7.  Inhibition of development of laser-induced choroidal neovascularization with suppression of infiltration of macrophages in Smad3-null mice.

Authors:  Hiroki Iwanishi; Norihito Fujita; Katsuo Tomoyose; Yuka Okada; Osamu Yamanaka; Kathleen C Flanders; Shizuya Saika
Journal:  Lab Invest       Date:  2016-03-07       Impact factor: 5.662

Review 8.  Monocyte subpopulations in angiogenesis.

Authors:  Heather J Dalton; Guillermo N Armaiz-Pena; Vianey Gonzalez-Villasana; Gabriel Lopez-Berestein; Menashe Bar-Eli; Anil K Sood
Journal:  Cancer Res       Date:  2014-02-20       Impact factor: 12.701

9.  Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa.

Authors:  Xue Cai; Shannon M Conley; Zack Nash; Steven J Fliesler; Mark J Cooper; Muna I Naash
Journal:  FASEB J       Date:  2009-12-01       Impact factor: 5.191

10.  Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration.

Authors:  Farzin Forooghian; Catherine Cukras; Catherine B Meyerle; Emily Y Chew; Wai T Wong
Journal:  Retina       Date:  2009-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.